The escalating tobacco usage and alcohol consumption, which can inflict damage on the cells lining the oral cavity, prompting the development of cancerous tumors, are the prime drivers of the oral neoplasms market.

1. Mouth Neoplasms
Market Research
Report 2023-2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Mouth Neoplasms Market 2023-2033
The newly published report by IMARC Group, titled ”Mouth Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth,
Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the mouth neoplasms market. The report provides an
overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease
overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent
advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced
by industry players.
Mouth Neoplasms Market Size:
The mouth neoplasms market is anticipated to grow at a CAGR of 3.84% during 2023-2033.
Request a Sample Report: https://www.imarcgroup.com/mouth-neoplasms-market/requestsample
3

4. Report Description and Highlights
What are mouth neoplasms?
Mouth neoplasms, alternatively known as oral neoplasms or oral tumors, are abnormal proliferations that emerge within the oral cavity.
They can manifest in various parts of the mouth, including the tongue, lips, cheeks, gums, the mouth’s floor, and the palate. Some of the
common symptoms include enduring mouth ulcers, oral lumps or growths, throat discomfort, difficulties with swallowing or chewing,
halitosis, loose teeth or shifts in dental alignment, and unexplained oral bleeding or numbness.
Oral neoplasm diagnosis entails an exhaustive assessment by a healthcare professional proficient in oral health and oral pathology.
Numerous imaging tests such as X-rays, computed tomography (CT), and magnetic resonance imaging (MRI) scans may be undertaken to
discern the neoplasm’s extent and location. Additional tests such as blood work and molecular profiling may be recommended to furnish
more insight into the tumor’s properties.
4

5. Report Description and Highlights
What are the key drivers and trends in the mouth neoplasms market?
The escalating tobacco usage and alcohol consumption, which can inflict damage on the cells lining the oral cavity, prompting the
development of cancerous tumors, are the prime drivers of the oral neoplasms market. Besides this, the rising prevalence of various
associated risk factors, including inadequate oral hygiene, nutritional deficiencies, excessive exposure to sunlight, and inherited genetic
syndromes, fosters a positive market outlook. Moreover, the extensive adoption of external beam radiation therapy, with its various
advantages such as targeted treatment, combinability with surgery or chemotherapy, improved local control, and pain management, is
fueling the market growth.
Concurrently, the rising implementation of transoral robotic surgery (TORS), which circumvents external incisions, thus minimizing trauma,
scarring, and potentially hastening recovery times, is aiding in market expansion. Furthermore, the growing popularity of advanced imaging
techniques, such as cone-beam computed tomography, facilitating real-time modifications to the radiation treatment plan to ensure
precise tumor radiation delivery while minimizing exposure to healthy tissues, is propelling the market forward.
5

6. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
6

7. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Mouth Neoplasms market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Mouth Neoplasms market
• Reimbursement scenario in the market
• In-market and pipeline drugs
7

8. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/mouth-neoplasms-market
8

9. Key Questions Answered in the Report
1. How has the Mouth Neoplasms market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Mouth Neoplasms market across the seven major markets in 2022 and what will it look like in
2033?
4. What is the growth rate of the Mouth Neoplasms market across the seven major markets and what will be the expected growth over
the next ten years?
5. What are the key unmet needs in the market?
9

10. Table of
Contents

11. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Mouth Neoplasms - Introduction
11

12. Table of Contents
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Mouth Neoplasms - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/mouth-neoplasms-
market/toc
12

13. Partial List Of Our Clients
13

14. OUR CLIENTS
14

15. Disclaimer
15
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.